Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

Software Refraction With Mobilerone Versus Retinoscopy

NCT06059521

Conditions: Astigmatism, Eye Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Airdoc MPC Opthalmology Clinics Beijing, Beijing Municipality, China

Jenny QIU Beijing, Beijing Municipality, China

Qiu Jenny Beijing, Haidian District, China

View Trial Details

Recruiting

Transplantation After Complete Response In Patients With T-cell Lymphoma

NCT05444712

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Chu D'Amiens - Hopital Sud Amiens, France

Chu D'Angers Angers, France

Ch Victor Dupouy Argenteuil, France

Ch D'Avignon - Hopital Henri Duffaut Avignon, France

View all 48 locations

View Trial Details

Recruiting

Go-CHOP as the Frontline Therapy for PTCL

NCT05963347

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma

NCT05846750

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tian, China

View Trial Details

Recruiting

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

NCT05899621

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

NCT05846763

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Frontline of ASCT in High-risk DLBCL

NCT05831865

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

NCT05842707

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shanghai Tongji Hospital, Tongji University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

NCT05833893

Conditions: Advanced Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +6 more
Locations: ChinaPLAGH Beijing, Haidian, China

View Trial Details

Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04920617

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Compassionate Cancer Care Medical Group Fountain Valley, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

BRCR Medical Center Inc. Hollywood, Florida, United States

BRCR Medical Center Inc. Plantation, Florida, United States

View all 50 locations

View Trial Details